
What smart money is saying about Mindray
1 fund in our archive has pitched Mindray — most recently Harding Loevner Global Equity in June 2025.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions. It also provides in-vitro diagnostics products, including hematology and chemistry analyzers and reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry products, and micro plate readers and washers, as well as coagulation, urinalysis, and microbiology solutions; medical imaging systems comprising ultrasound and radiology products; and veterinary products. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.
Get an email when a fund writes about it
Fund coverage · 1 thesis
- Harding Loevner Global EquityJune 2025
Mindray is leveraging AI in its medical devices to enhance diagnostic accuracy and efficiency, positioning itself as a strong competitor in the high-end ultrasound market and achieving significant growth in international markets.
Read the full thesis
Read every full thesis on Mindray
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→